In a significant move to bolster its oncology division, Merck KGaA, the Darmstadt-based pharmaceutical and technology conglomerate, has announced the acquisition of Springworks Therapeutics, a US biotech firm specializing in cancer therapies, for approximately $3 billion. This acquisition, priced at $47 per share, marks Merck's largest in the healthcare sector in recent years and is poised to accelerate the company's growth in the medium to long term.
Springworks Therapeutics, headquartered in Stamford, Connecticut, has carved a niche in developing treatments for rare tumors and blood cancers. Its flagship product, Ogsiveo, has already received US approval for treating advanced desmoid tumors, a rare form of soft tissue tumor. Analysts from JP Morgan project that Ogsiveo could achieve peak sales of around $1 billion, underscoring the potential of this acquisition to significantly enhance Merck's portfolio in rare oncology treatments.
The deal comes at a time when Merck is under pressure to replenish its pipeline following setbacks in clinical trials for several high-potential drugs. By acquiring Springworks, Merck not only gains access to a promising oncology portfolio but also strengthens its presence in the US market, a strategic move that aligns with its focus on rare diseases and specialized therapies.
This acquisition is part of Merck's broader strategy to diversify its healthcare offerings through both licensing agreements and strategic takeovers. The last major acquisition by Merck was in 2019, when it purchased Versum Materials, a US semiconductor supplier, for about €5.8 billion. The Springworks deal underscores Merck's commitment to expanding its footprint in the high-growth oncology sector, signaling a new chapter in its pursuit of innovation and market leadership in specialized medicine.
MUNICH — Knorr-Bremse AG, the German manufacturer of braking systems for trucks and trains, announced on Monday it has agreed to acquire Dutch digital services platform TRAVIS Road Services International B.V. The deal, valued in the mid-double-digit million-euro range, represents the latest...
Hundreds of demonstrators gathered at Berlin's Brandenburg Gate on Sunday evening, forming a sea of lights with mobile phone torches and lighters to protest for diversity and against racism. The rally came just days after German Chancellor Friedrich Merz made controversial comments about...
The small German municipality of Schwanau in Baden-Württemberg has become the unlikely stage for an escalating conflict between local government and one of the region's largest employers. The dispute centers around approximately 20 flower pots installed by the municipality two months ago...
Thyssenkrupp Marine Systems (TKMS), Germany's largest naval shipbuilder, made a strong debut on the Frankfurt Stock Exchange Monday, with shares trading significantly above initial expectations. The stock opened at €60 per share, far surpassing analyst forecasts of approximately €36, and...
Swiss cement conglomerate Holcim has agreed to acquire German building materials manufacturer Xella for €1.85 billion, marking a significant strategic move in the European construction sector. The transaction, announced on Monday, is expected to be finalized in the second half of 2026,...
